Re: A Population-Based Nested Case-Control Study: The Use of 5-Alpha-Reductase Inhibitors and the Increased Risk of Osteoporosis Diagnosis in Patients with Benign Prostate Hyperplasia.
Steven A
SA
Kaplan
D058891:5-alpha Reductase Inhibitors; D016022:Case-Control Studies; D006801:Humans; D006965:Hyperplasia; D008297:Male; D010024:Osteoporosis; D010088:Oxidoreductases; D011470:Prostatic Hyperplasia
D058891:5-alpha Reductase Inhibitors; D010088:Oxidoreductases